AstraZeneca has received priority review from the US Food and Drug Administratio...
While the vaccine demonstrated high responses for neutralizing influenza A titer...
As part of pipeline reprioritisation, Acelyrin has dropped izokibep and will ins...
In 2021, the Centers for Disease Control and Prevention estimated that 49 percen...
NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an ex...
The Ministry of Health and Prevention in the UAE has granted approval for BioArc...
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan), has received ...
Eli Lilly and Company has opened the Lilly Seaport Innovation Center (LSC), an R...
The court rebuffed claims by Novartis that it would experience “irreparable harm...
IGNYTE-3 is a Phase III trial investigating Replimune’s flagship oncolytic treat...
Kezar plans to focus all efforts on zetomipzomib, which is being evaluated in tw...
Africa CDC’s director general Dr. Jean Kaseya stated the number of rising mpox c...
Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the p...
As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biot...
Sable Therapeutics has signed an agreement with Columbia University to develop n...
The US FDA has approved ARS Pharmaceuticals' neffy, an anyphylaxis nasal spray 2...
